Status:
COMPLETED
Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic Studies
Lead Sponsor:
The Cleveland Clinic
Conditions:
Sleep Apnea
Adverse Event
Eligibility:
All Genders
18+ years
Brief Summary
Investigators hypothesize that the obese population (BMI ≥30 kg/m2) who might be at higher risk for obstructive sleep apnea (OSA), carries a higher risk of endoscopy associated adverse events. The pri...
Detailed Description
Obstructive sleep apnea (OSA) is a chronic condition characterized by episodes of apnea and hypoxemia caused by upper airway collapse. These episodes lead to symptoms such as daytime fatigue and sleep...
Eligibility Criteria
Inclusion
- Undergoing elective upper endoscopy or colonoscopy
- Body mass index equal or greater than 25 kg/m2
Exclusion
- Patients \<18 years of age
- pregnant women
- lung disease requiring oxygen
- oxygen saturation less or equal to 90% at the beginning of endoscopy
- BMI \<25
- ASA ≥4
- Inability to obtain consent
Key Trial Info
Start Date :
February 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 18 2021
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT03436381
Start Date
February 9 2018
End Date
December 18 2021
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Florida
Weston, Florida, United States, 33331